Mass Loss in Population II Red Giants: an IRAC@Spitzer Survey of Galactic Globular Clusters

With the goal of studying ML along the RGB, mid-IR observations of a carefully selected sample of 17 Galactic globular clusters (GGCs) with different metallicity and horizontal branch (HB) morphology have been secured with IRAC on board Spitzer: a global sample counting about 8000 giant has been obtained. Suitable complementary photometry in the optical and near-IR has been also secured in order to properly characterize the stellar counterparts to the Spitzer sources and their photospheric parameters. Stars with color (i.e. dust) excess have been identified, their likely circumstellar emission quantified and modelled, and empirical estimates of mass loss rates and timescales obtained. We find that mass loss rates increases with increasing stellar luminosity and decreasing metallicity. For a given luminosity, we find that ML rates are systematically higher than the prediction by extrapolating the Reimers law. CMDs constructed from ground based near-IR and IRAC bands show that at a given luminosity some stars have dusty envelopes and others do not. From this, we deduce that the mass loss is episodic and is ``on'' for some fraction of the time. The total mass lost on the RGB can be easily computed by multiplying ML rates by the ML timescales and integrating over the evolutionary timescale. The average total mass lost moderately increases with increasing metallicity, and for a given metallicity is systematically higher in clusters with extended blue HB.

Cellular and molecular effects of cross reacting material 197 (CRM197) on HT-29 colon cancer cell line

Cross Reacting Material 197(CRM197) is a Diphteria toxin non toxic mutant that had shown anti-tumor activity in mice and humans. CRM197 is utilized as a specific inhibitor of heparin-binding epidermal growth factor (HB-EGF), that competes for the epidermal growth factor receptor (EGFR), overexpressed in colorectal cancer and implicated in its progression. We evaluated the effects of CRM197 on HT-29 human colon cancer cell line behaviour and, for CRM197 recognized ability to inhibit HB-EGF, its possible effects on EGFR activation. In particular, while HT-29 does not show any reduction of viability after CRM197 treatment, or changes in cell cycle distribution, in EGFR localization or activation, they show a change in gene expression profile analyzed by microarray. This is the first study where the CRM197 treatment on HT-29 show the alteration of a specific and selected number of genes.

Influence of Electromagnetic Fields On Biological Signalling: An Experimental and Theoretical Approach

The primary goals of this study were to develop a cell-free in vitro assay for the assessment of nonthermal electromagnetic (EMF) bioeffects and to develop theoretical models in accord with current experimental observations. Based upon the hypothesis that EMF effects operate by modulating Ca2+/CaM binding, an in vitro nitric oxide (NO) synthesis assay was developed to assess the effects of a pulsed radiofrequency (PRF) signal used for treatment of postoperative pain and edema. No effects of PRF on NO synthesis were observed. Effects of PRF on Ca2+/CaM binding were also assessed using a Ca2+-selective electrode, also yielding no EMF Ca2+/CaM binding. However, a PRF effect was observed on the interaction of hemoglobin (Hb) with tetrahydrobiopterin, leading to the development of an in vitro Hb deoxygenation assay, showing a reduction in the rate of Hb deoxygenation for exposures to both PRF and a static magnetic field (SMF). Structural studies using pyranine fluorescence, Gd3+ vibronic sideband luminescence and attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy were conducted in order to ascertain the mechanism of this EMF effect on Hb. Also, the effect of SMF on Hb oxygen saturation (SO2) was assessed under gas-controlled conditions. These studies showed no definitive changes in protein/solvation structure or SO2 under equilibrium conditions, suggesting the need for real-time instrumentation or other means of observing out-of-equilibrium Hb dynamics. Theoretical models were developed for EMF transduction, effects on ion binding, neuronal spike timing, and dynamics of Hb deoxygenation. The EMF sensitivity and simplicity of the Hb deoxygenation assay suggest a new tool to further establish basic biophysical EMF transduction mechanisms. If an EMF-induced increase in the rate of deoxygenation can be demonstrated in vivo, then enhancement of oxygen delivery may be a new therapeutic method by which clinically relevant EMF-mediated enhancement of growth and repair processes can occur.